Evidence map›Paper›PMID 25411386›Full record

ArticleAmerican journal of physiology. Renal physiology2015

Angiotensin II increases fibronectin and collagen I through the β-catenin-dependent signaling in mouse collecting duct cells.

Catherina A Cuevas, Alexis A Gonzalez, Nibaldo C Inestrosa, Carlos P Vio, Minolfa C Prieto

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. The Perspective of Vitamin D on suPAR-Related AKI in COVID-19.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Heme Oxygenase 1: A Defensive Mediator in Kidney Diseases.International journal of molecular sciences · 2021
    Review
  13. Article
  14. Article
  15. The Emerging Role of Innate Immunity in Chronic Kidney Diseases.International journal of molecular sciences · 2020
    Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Catherina A CuevasDepartment of Physiology, Center of Aging and Regeneration CARE UC, Pontificia Universidad Católica de Chile, Santiago, Chile; Department of Cell and Molecular Biology, Center of Aging and Regeneration CARE UC, Pontificia Universidad Católica de Chile, Santiago, Chile; Department of Physiology, Tulane University, New Orleans, Louisiana; and.
Alexis A GonzalezInstituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile;
Nibaldo C InestrosaDepartment of Cell and Molecular Biology, Center of Aging and Regeneration CARE UC, Pontificia Universidad Católica de Chile, Santiago, Chile;
Carlos P VioDepartment of Physiology, Center of Aging and Regeneration CARE UC, Pontificia Universidad Católica de Chile, Santiago, Chile;
Minolfa C PrietoDepartment of Physiology, Tulane University, New Orleans, Louisiana; and Department of Hypertension and Renal Center of Excellence, Tulane University, New Orleans, Louisiana mprieto@tulane.edu.
Pontificia Universidad Católica de Chile · CLPontificia Universidad Católica de Valparaíso · CLTulane University · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
Translational Research in Hypertension and Renal BiologyP30GM103337 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI NAVAR, LUIS GABRIEL · 2012 to 2016
$5.8M
PLEIOTROPIC EFFECTS OF PRORENIN RECEPOR IN COLLECTING DUCT AND INTRARENAL RAS ACTIVATIONR01DK104375 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI PRIETO, MINOLFA C · 2014 to 2018
$1.7M
NIDDK NIH HHS 1 R01 DK104375-01NIDDK NIH HHS R01 DK104375NIGMS NIH HHS P30 GM103337NIGMS NIH HHS P30GM103337NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

The contribution of angiotensin II (ANG II) to renal and tubular fibrosis has been widely reported. Recent studies have shown that collecting duct cells can undergo mesenchymal transition suggesting that collecting duct cells are involved in interstitial fibrosis. The Wnt/β-catenin signaling pathway plays an essential role in development, organogenesis, and tissue homeostasis; however, the dysregulation of this pathway has been linked to fibrosis. In this study, we investigated whether AT1 receptor activation induces the expression of fibronectin and collagen I via the β-catenin pathway in mouse collecting duct cell line M-1. ANG II (10(-7) M) treatment in M-1 cells increased mRNA, protein levels of fibronectin and collagen I, the β-catenin target genes (cyclin D1 and c-myc), and the myofibroblast phenotype. These effects were prevented by candesartan, an AT1 receptor blocker. Inhibition of the β-catenin degradation with pyrvinium pamoate (pyr; 10(-9) M) prevented the ANG II-induced expression of fibronectin, collagen I, and β-catenin target genes. ANG II treatment promoted the accumulation of β-catenin protein in a time-dependent manner. Because phosphorylation of glycogen synthase kinase-3β (GSK-3β) inhibits β-catenin degradation, we further evaluated the effects of ANG II and ANG II plus pyr on p-ser9-GSK-3β levels. ANG II-dependent upregulation of β-catenin protein levels was correlated with GSK-3β phosphorylation. These effects were prevented by pyr. Our data indicate that in M-1 collecting duct cells, the β-catenin pathway mediates the stimulation of fibronectin and collagen I in response to AT1 receptor activation.

Indexed as

ActinsAngiotensin IIAngiotensin II Type 1 Receptor BlockersAnimalsbeta CateninCell LineCollagen Type ICyclin D1FibronectinsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaKidney Tubules, CollectingMiceMyofibroblastsPhenotypePhosphorylationActinsalpha-smooth muscle actin, mouseAngiotensin IIAngiotensin II Type 1 Receptor Blockersbeta CateninCcnd1 protein, mouseCollagen Type ICTNNB1 protein, mouseCyclin D1FibronectinsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGsk3b protein, mouseMyc protein, mouseProto-Oncogene Proteins c-mycReceptor, Angiotensin, Type 1RNA, Messengermouse collecting duct cellpyrvinium pamoatetissue homeostasis

Identifiers

PMID25411386
PMCPMC4329493
OpenAlexW2136143828

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.